Related Experiment Video
Updated: Jul 10, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Retinoblastoma: review of current management
Murali Chintagumpala1, Patricia Chevez-Barrios, Evelyn A Paysse
1Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. mxchinta@txccc.org
Insights
Retinoblastoma, a common childhood eye cancer, is treatable with high cure rates when detected early. Management involves a multidisciplinary team and tailored treatments based on disease stage and laterality.
Area of Science:
- Ophthalmology
- Pediatric Oncology
- Genetics
Background:
- Retinoblastoma is the most frequent primary ocular malignancy in children, affecting approximately 300 U.S. children annually.
- The disease can manifest in one or both eyes and may have a hereditary component.
- Key symptoms prompting medical evaluation include abnormal pupil discoloration and strabismus.
Purpose of the Study:
- To provide an overview of retinoblastoma diagnosis, treatment, and management.
- To highlight the importance of a multidisciplinary approach in optimizing patient care.
- To discuss treatment strategies based on disease characteristics and the risk of secondary malignancies.
Main Methods:
- Diagnosis involves appropriate studies following initial clinical presentation.
- Treatment strategies encompass enucleation, chemotherapy, radiation therapy, and local ophthalmic therapies.
- Management decisions are guided by disease laterality (unilateral/bilateral), stage, and patient age.
Main Results:
- Optimal short- and long-term outcomes are frequently achieved through multidisciplinary care.
- High cure rates are attainable when the tumor is confined within the eye.
- Children with heritable retinoblastoma face an elevated risk of secondary malignancies, particularly sarcomas, especially after early-life radiation exposure.
Conclusions:
- Early detection and a comprehensive, multidisciplinary approach are crucial for successful retinoblastoma management.
- Tailored treatment based on individual disease factors improves cure rates and minimizes long-term toxicities.
- Ongoing research, including insights from animal models, is paving the way for novel targeted therapies with potentially reduced side effects.
Abstract:
The most common ocular cancer in children is retinoblastoma. It affects approximately 300 children in the U.S. every year. It can affect one or both eyes and the disease can be inherited. Altered discoloration of the pupil and strabismus are the usual symptoms that lead to medical attention. Subsequent appropriate diagnostic studies and care provided by a multidisciplinary team, including an ophthalmologist, a pediatric oncologist, a radiation oncologist, and a geneticist, among others, often result in optimal short-term and long-term care. The best initial and subsequent treatments are based on whether the child has unilateral or bilateral disease, the stage of the disease, and the age of the child. Enucleation, chemotherapy, and various forms of radiation therapy along with local ophthalmic therapies can be used in the treatment of retinoblastoma. Cure rates are high in children when the tumor is confined to the eye and has not spread systemically or into the orbit or brain. Children with the heritable form of retinoblastoma are at high risk for developing subsequent malignancies, most commonly sarcomas. This risk is greater for those children with the heritable form of the disease who were exposed to ionizing radiation at age <1 year. Exciting discoveries using animal models are providing new insights into the development of this disease and opening new avenues for targeted therapies that may lead to high cure rates with minimal toxicities.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...